Macquarie Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,215
| Closed | -$25 | – | 1974 |
|
|
2024
Q1 | $25 | Buy |
+9,215
| New | +$25 | ﹤0.01% | 1678 |
|
|
2021
Q4 | – | Sell |
-976
| Closed | -$12K | – | 2616 |
|
|
2021
Q3 | $12K | Hold |
976
| – | – | ﹤0.01% | 2519 |
|
|
2021
Q2 | $21K | Hold |
976
| – | – | ﹤0.01% | 2351 |
|
|
2021
Q1 | $27K | Sell |
976
-390
| -29% | -$10.8K | ﹤0.01% | 2217 |
|
|
2020
Q4 | $36K | Hold |
1,366
| – | – | ﹤0.01% | 2110 |
|
|
2020
Q3 | $51K | Hold |
1,366
| – | – | ﹤0.01% | 1949 |
|
|
2020
Q2 | $70K | Buy |
+1,366
| New | +$70K | ﹤0.01% | 1849 |
|
|
2018
Q3 | – | Sell |
-16,395
| Closed | -$642K | – | 2185 |
|
|
2018
Q2 | $642K | Sell |
16,395
-35,364
| -68% | -$1.38M | ﹤0.01% | 1291 |
|
|
2018
Q1 | $3.74M | Buy |
51,759
+31,048
| +150% | +$2.25M | 0.01% | 835 |
|
|
2017
Q4 | $1.36M | Sell |
20,711
-2,618
| -11% | -$172K | ﹤0.01% | 1146 |
|
|
2017
Q3 | $1.17M | Sell |
23,329
-2,220
| -9% | -$111K | ﹤0.01% | 1159 |
|
|
2017
Q2 | $1.18M | Buy |
+25,549
| New | +$1.18M | ﹤0.01% | 1117 |
|